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Abstract
Introduction: Proteus mirabilis bacilli play an important role in human urinary tract infections, bacteremia, and rheumatoid
arthritis. The authors previously studied human complement C3 conversion by smooth-form P. mirabilis O10, O23, O30, and
O43 lipopolysaccharides (LPSs) and showed that smooth Proteus LPSs fragmented C3 in a dose- and time-dependent man-
ner. In the present study, one smooth P. mirabilis S1959 and its two polysaccharide-truncated LPSs isolated from an R
mutant strain were used to study the C3 conversion. 
Materials and Methods: The conversion of C3 to C3c by smooth and rough P. mirabilis LPSs was studied by capture ELISA
and crossed immunoelectrophoresis. Proteins isolated from the outer membrane were analyzed by discontinuous sodium
dodecyl sulfate gel electrophoresis.
Results: The smooth P. mirabilis S1959 (O3) strain was resistant to the bactericidal activity of human serum, in contrast to
the Ra and Re mutant strains. The presence of an exposed core oligosaccharide in R110 LPS was not sufficient to protect
the strain from serum-dependent killing. In addition to LPS structure, the outer-membrane proteins may also play roles in
protecting the smooth P. mirabilis S1959 (O3) strain from the bactericidal action of serum. It was shown that the Ra P.
mirabilis R110 and the Re P. mirabilis R45 mutants possess very different OMP compositions from that of the P. mirabilis S
1959 strain. 
Conclusion: Regardless of the complement resistance of the P. mirabilis strains, the S1959, R110, and R45 LPSs fragment-
ed C3 and induced C3c neo-antigen exposure. The use of complement-deficient human serum allows the conclusion that the
Re-type P. mirabilis R45 LPS fragmented C3 by the antibody-independent classical pathway. 
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INTRODUCTION
One of the functions of the complement (C) system
in host defense is self/non-self recognition (Blatteis et
al. 2004; Vukajlovich et al. 1987). The lipopolysaccha-
rides (LPSs) and outer-membrane proteins (OMPs)
located on the outer membrane of Gram-negative bac-
teria are important targets for the bactericidal action
of the complement system (Biedzka-Sarek et al. 2005;
Blatteis et al. 2004; Hostetter 1993; Vukajlovich et al.
1987). The structure of the O-specific side chain of
LPS and any structural change in or chemical modifi-
cation of it play important roles in the resistance of
bacterial cells to the lytic activity of complement
(Lachowicz and Doroszkiewicz 1996; Lachowicz et al.
1999; Taylor 1992). OMPs are probably responsible for
the different levels of sensitivity of some Gram-nega-
tive strains to the bactericidal activity of complement
(Cisowska et al. 2005; Futoma-Ko³och et al. 2006; Pilz
et al. 1992).
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There are different mechanisms of LPS-mediated
complement activation. The antibody-independent clas-
sical pathway (CP) is mediated only by the lipid A por-
tion of the molecule. Activation of the alternative path-
way requires polysaccharide moieties of LPS: core
oligosaccharide and/or O-antigen polysaccharides
(Besucher and Brade 1986; Biedzka-Sarek et al. 2005;
Gardiner et al. 1991; Vukajlovich et al. 1987). Poly-sac-
charides are also required by the lectin pathways of
complement activation with involvement of mannose-
-binding protein (MBP) (Chonn et al. 1991; Ohta et al.
1990). The C3 molecules play a pivotal role in the junc-
tions of the three pathways of complement activation
(Becherer et al. 1990; Hostetter 1993; Hostetter and
Gordon 1987). The C3 moieties link the different com-
plement pathways of activation and C3’s fragmentation
in serum give rises to C3a, C3b, iC3b, C3c, and C3d
(Becherer et al. 1990; Hostetter and Gordon 1987).
Complement activation starts the inflammatory process-
es, which in some cases may end with the deteriorating
effects of overreactions, as observed in endotoxin shock
(Blatteis et al. 2004; Hostetter 1993). Complement acti-
vation and C3 fragmentation by Proteus mirabilis S and
R LPSs may enhance the inflammatory response.
P. mirabilis bacilli play an important role in human
urinary tract infections, bacteremia, and rheumatoid
arthritis (Ró¿alski et al. 1997). We previously studied
C3 conversion by smooth-form P. mirabilis O10, O23,
O30, and O43 LPSs (Kaca et al. 2000). We showed that
smooth Proteus LPSs fragmented C3 in a dose- and
time-dependent manner (Kaca et al. 2000). In the pre-
sent study, one smooth P. mirabilis S1959 and its two
polysaccharide-truncated LPSs isolated from an R
mutant strain were used to study C3 conversion. The 
P. mirabilis S1959 strain was classified to the O3
serogroup and its O-polysaccharide chain is built up of
pentasaccharide repeating units with amidically linked
lysine residues (Amano et al. 1996; Zió³kowski et al.
1997). The polymer of the pentasaccharide repeating
units of the O3-antigen is attached to a core oligosac-
charide characterized by the presence of D-galacturon-
ic acid residues in both the terminal and inter-chain
positions (Vinogradov et al. 2000). By chemical muta-
tion of the parent smooth P. mirabilis S1959 strain, two
mutants producing polysaccharide-truncated LPSs
were isolated. The P. mirabilis R110 strain produces
Ra-type LPS with a complete core oligosaccharide, but
lacks the O-antigen (Vinogradov et al. 2000). The 
P. mirabilis R45 strain contains a truncated core
oligosaccharide (Re-type) LPS (Amano et al. 1996;
Ró¿alski et al. 1997; Vinogradov et al. 2000;
Vinogradov et al. 1994; Zió³kowski et al. 1997). We
tried to correlate C3 fragmentation with complement-
-mediated bacteriolysis and the role of the core and
O-polysaccharide parts of the P. mirabilis LPSs in these
reactions. We also determined the electrophoretic pat-
terns of OMPs isolated from P. mirabilis S1959 and its
two R LPS mutants. 
MATERIALS AND METHODS
Bacteria and growth conditions
P. mirabilis O10, S1959 (OXK, O3), and its two R
mutants Ra (R110) and Re (R45) were obtained from
the Institute of Microbiology and Immunology,
University of £ódŸ, Poland. The bacteria were cultivat-
ed under aerobic conditions in nutrient broth. The com-
plete structures of the lipid A portion, core oligosaccha-
ride, and O-polysaccharide of the S1959, R110, and R45
LPSs were presented previously (Amano et al. 1996;
Ró¿alski et al. 1997; Vinogradov et al. 2000; Vinogradov
et al. 1994; Zió³kowski et al. 1997).
Lipopolysaccharides
Lipopolysaccharides were isolated from the smooth
Proteus strains by the hot phenol-water extraction
method (Westphal and Jann 1965). The Proteus LPSs of
R form were extracted by the phenol-chloroform-petro-
leum ether method (Galanos et al. 1969). The LPSs
were purified by DNase and RNase (Sigma Chemical
Co. St. Louis, MO, USA) treatment and ultracentrifu-
gation, as described (Amano et al. 1996; Zió³kowski et
al. 1997). All LPSs were essentially free of nucleic acids
and contained less than 2% proteins. Delipidation of
LPS was performed using 1% acetic acid at 100°C until
lipid A precipitated. The insoluble lipid fraction was
pelletted by centrifugation (15,000×g for 60 min). The
supernatant was fractionated on a Sephadex G-50 col-
umn (Pharmacia Fine Chemicals, Uppsala, Sweden).
The O-specific polysaccharide (F1 fraction) and the
core oligosaccharide (F2 fraction) were eluted with 0.05
M pyridine acetate buffer, pH 4.5. The triethylamine
salt of Salmonella minnesota 595 LPS was from stock at
the Division of Clinical Bacteriology, Karolinska
Institute, Huddinge University Hospital, Huddinge,
Sweden.
Complement
Blood samples were taken from healthy donors by
vein puncture and collected into dry vacutainer tubes.
The samples were allowed to clot for about 1 h at room
temperature and centrifuged at 4°C. The serum was
frozen in liquid nitrogen and stored in 0.2-ml aliquots at
–70°C until tested (Andersson et al. 2005).
Complement-deficient serum was from the Department
of Medical Microbiology, Section of Clinical
Immunology, Lund University, Lund, Sweden. The
serum depletion procedures were described previously
(Fredrikson et al. 1999; Johnson and Holmström 1982;
Sjöholm et al. 1982). In the complement-deficient
serum the classical, lectin, and alternative pathways did
not function due to the depletion of antibodies, P, D,
and MBL complement proteins (Fredrikson et al. 1999;
Johnson and Holmström 1982; Sjöholm et al. 1982). To
this deficient serum was added C1q (10% of the normal
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amount). Therefore the antibody-independent classical
pathway of activation was restored and this serum was
designated as C1qD. The serum antibody titer of anti-
S1959, -R110, and -R45 LPS was 1:100, measured by
enzyme-linked immunosorbent assay (ELISA). In the
C1qD complement-deficient serum, anti-P. mirabilis
LPS antibodies were not detected. 
Hemolytic complement assay
Complement fixation was determined by lysis of sen-
sitized sheep red blood cells by antibodies as described
(Kaca and Roth 1995). V-bottomed microtiter plates
(NUNC, Denmark) were used. Serial dilutions of bacte-
rial dry masses or LPS in veronal buffer (VB, 50 µl), pH
7.4, 0.15 mM CaCl2, 1 mM MgCl2, and 0.01% gelatin
(Ohta et al. 1990) were incubated for 30 min at 37°C
with 50 µl of serum (Sigma) 1:5 diluted in VBMgCa.
This dilution is sufficient to produce 60–80% lysis of the
erythrocytes. Mixtures of LPS and serum were incubat-
ed for 60 min at 37°C under gentle mixing with 50 ml of
sensitized sheep erythrocytes and unlysed erythrocytes
were pelleted (3000×g for 15 min). Ninety ml of the
supernatants were transferred to flat-bottom Costar
microtiter plates and the quantity of free hemoglobin
was measured at 405 nm using a multichannel plate read-
er (Multiscan). Replicate wells (3–8) were run for each
experimental sample and each experiment was repeated
at least two times. Representative results are shown. 
C3 conversion detected by capture ELISA
ELISA measurements of C3 conversion to lower-
-molecular-mass fragments were based on a method
described by Holmskov-Nielsen (Holmskov-Nielsen et
al. 1986; Garred et al 1988). The assay detects (relative
to the control) C3c neo-determinant increases in C3
low-molecular-mass fragments after C3 fragmentation
by exposure to complement-activating agents. The
method was run as described by us previously (Kaca et
al. 2000). The human serum and LPS (10 µg/ml) were
incubated for 45 min at 37°C and the reaction was
stopped by 1/2000 dilution in ice-cold phosphate buffer
saline (PBS) supplemented with 10 mM EDTA and
0.2% Tween. Then the diluted mixtures of serum and
LPS were transferred to plates (flat-bottom high-bind-
ing Costar, Cambridge, USA) pre-coated for 2 h at 37°C
with rabbit anti-human C3c antibodies (DAKO A/S,
Denmark) diluted 1/500 in 0.1 M sodium carbonate
buffer, pH 9.6. The pre-coated plates with diluted mix-
tures of serum and LPS were incubated for 2 h at 10°C
and the amounts of captured C3c fragments were then
detected by incubation for 30 min at 37°C with sec-
ondary horseradish peroxidase-conjugated rabbit anti-
-human C3c antibodies (DAKO A/S, Denmark, diluted
1/2000 in PBS, 1% BSA, and 0.2% Tween). After each
step the plates were washed eight times with PBS
(Titrek microplate washer, M96V, ICN Flow, England).
The enzyme activity remaining in the wells was deter-
mined by adding 0.1 ml OPD (1,2-phenylenediamine
dichloride, DAKO A/S, Denmark) solution. After 10
min at room temperature the reaction was stopped by
0.1 ml of 0.5 M H2SO4. The absorbance at 492 nm was
read using a multichannel spectrophotometer
(Labsystems Multiscan Plus, Finland). As a negative
control, serum alone or heat-inactivated serum (30 min,
56°C) was used in each experiment. Three to nine repli-
cate wells were run for each experimental sample and
each experiment was repeated at last three times. 
Crossed immunoelectrophoresis
Human C3 conversion was detected with crossed
immunoelectrophoresis, as previously described
(Johnson and Holmström 1982). The human comple-
ment, diluted to 90% in PBS, was activated by LPS (10
µg/ml) at 37°C for 15 min. The reaction was stopped by
dilution in ice-cold PBS supplemented with 10 mM
EDTA. The human complement proteins were separat-
ed first by agarose gel (0.6%, Seakem, FMC, USA) elec-
trophoresis (1 V/cm) in 0.075 M veronal buffer supple-
mented with 2 mM EDTA for 1 hr at 8°C. The proteins
separated by the first electrophoresis were transferred
to a second agarose gel containing 0.6% rabbit anti-
human C3c (DAKO A/S, Denmark). The second elec-
trophoresis was performed at 1 V/cm for 3 h and the gels
were pressed and fixed and the precipitates stained with
Coomassie blue (0.5%).
Isolation of the OMPs (with modification)
The OMPs were isolated from bacteria grown in 100
ml of brain-heart infusion broth (Difco) at 37°C for 18 h
(Murphy and Bartos 1989). After incubation the bacter-
ial cells were centrifuged (4000 rpm at 4°C for 20 min)
and the pellet was suspended in 2.5 ml of buffer B (1 M
sodium acetate, 0.001 M β-mercaptoethanol, pH 4.0).
Then a 22.5-ml water solution containing 5% Zwitter-
gent Z 3-14 (Calbiochem-Behring) and 0.5 M CaCl2 was
added. This mixture was stirred at room temperature for
1 h. To precipitate nucleic acids, 6.25 ml of 96% cold
ethanol was added very slowly. The mixture was then
centrifuged at 12,300 rpm at 4°C for 10 min. The
remaining proteins were precipitated by the addition of
93.5 ml of 96% cold ethanol and centrifuged at 12,300
rpm at 4°C for 20 min. The pellet was suspended in 5 ml
of buffer Z (0.05% Zwittergent, 0.05 M Tris, and 0.01 M
EDTA, pH 8.0) and stirred at room temperature for 1 h.
The solution was kept at 4°C overnight and centrifuged
at 8700 rpm at 4°C for 10 min. OMPs were presented in
the buffer Z soluble fraction after centrifugation. The
Bradford protein assay was used to measure the con-
centration of proteins in the samples (Bradford 1976).
Polyacrylamide gel electrophoresis
Discontinuous sodium dodecyl sulfate gel elec-
trophoresis (SDS-PAGE) was carried out on slabs with
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12.5% acrylamide according to Laemmli(Laemmli 1970).
The OMPs prepared in the sample buffer were loaded in
each of the wells at the same volume of 10 µl. The sam-
ples were applied to slabs after heating at 100°C for 4 min
with sample buffer. The Wide Molecular Weight Range
Sigma Marker protein standard (twelve proteins from
6–205 kDa) was used for molecular-mass calibration.
Electrophoresis was carried out at 100 V for 15 min and
then at 200 V for 45 min. When electrophoresis was com-
pleted, the gels were kept for 1 h in a solution containing
25% methanol, 10% acetic acid, and 0.05% Coomassie
brilliant blue and destained in 10% acetic acid for 3–5 h.
The molecular masses of the OMP’s were analyzed with
Quantity One v. 4.0.1 software.
Complement-mediated bactericidal assay
Proteus strains were grown overnight in Mueller-
-Hinton broth. When the cultures reached an absorbence
of 0.6 at 640 nm (A640), they were diluted in PBS in V-
-bottomed microtiter plates (NUNC, Denmark) to
about 100 cells per well. The number of bacterial cells
was confirmed by the colony forming units (CFU) plate
method. Reaction mixtures were prepared by combining
25 µl of the bacterial suspension and 75 µl of human
sera. Bacterial cells with sera were incubated for 5, 30,
and 60 min at 37°C with shaking and then 100 µl of cold
Mueller-Hinton broth was added. Resistant bacterial
cells were cultivated for 16 h at 37°C with shaking and
then sedimented (3000×g for 15 min). The bactericidal
activities of the serum were evaluated in reactions con-
taining active serum (intact complement source, C),
heat-inactivated serum (50°C for 20 min, alternative
pathway inactivated, classical active, C-CP), and in the
control samples containing inactive complement (C-In,
30 min at 56°C) (Kaca et al. 2000; Vukajlovich et al.
1987). Three replicate wells were run for each experi-
mental sample and each experiment was repeated at last
three times. Representative results are presented. The
bacteriocidal assays on microtiter plates were confirmed
by the plate method, as described (Futoma-Ko³och et al.
2006).
RESULTS
Complement-mediated bactericidal effect on smooth and
rough P. mirabilis strains
The complement-mediated bactericidal effect was
tested under conditions in which only a few bacterial
cells (about 100) were exposed to the serial human
serum dilutions (Table 1). This condition resembles the
natural way of invasion, in which few bacteria enter the
blood vessels. The native serum diluted up to 0.15%
killed the P. mirabilis Ra and Re mutants. The smooth
S1959 cells were resistant in all the serum dilutions used.
Five-minute incubation at 37°C with the native C and 
Table 1. The bactericidal effect of human sera on the P. mirabilis S1959, R110, and R45 strains
LPS Serum Time Serum dilution (%)
(min)
75 50 10 5 2.5 1.25 0.62 0.31 0.15 0.07
S1959 C 5 +** + + + + + + + + +
30 + + + + + + + + + +
60 + + + + + + + + + +
C-CP 60 + + + + + + + + + +
C-In 60 + + + + + + + + + +
R110 C 5 –* – – – – – – – + +
30 – – – – – – – – + +
60 – – – – – – – – + +
C-CP 60 – – – – – + + + + +
C-In 60 + + + + + + + + + +
R45 C 5 – – – – – – – – + +
30 – – – – – – – – + +
60 – – – – – – – – + +
C-CP 60 – – – – – + + + + +
C-In 60 + + + + + + + + + +
* No traces of bacterial sediment. ** Sediment of bacteria after 5, 30, and 60 min of incubation at 37°C. C – native serum (com-
plement active), C-CP – heat-inactivated serum at 50°C for 20 min. (CP – classical pathway inactive, alternative pathway of com-
plement active), C-In – heat-inactivated serum at 56°C for 30 min (copmplement inactive). The samples were run in duplicate and
repeated at least three times. Representative results are presented.
W. Kaca et al.: Complement activation by P. mirabilis 387
C-CP sera was sufficient to kill the R mutants (Table 1).
The micotiter plate results were confirmed by the CFU
plate method. The number of P. mirabilis S1959 cells
increased from 2×107 to 5×107 after 60 min of incubation
in the 50% human C dilution. That is in agreement with
previously published data (Futoma-Ko³och et al. 2006).
In contrast to the smooth S1959 strain, the two R
mutant strains were sensitive to the bactericidal action
and did not grow in native C and C-CP diluted to 50%
in PBS. This indicates that the classical pathway of com-
plement activation plays an important role in preventing
the growth of the P. mirabilis R110 and R45 mutant
strains. The presence of the O-polysaccharide of LPS on
the surface of the P. mirabilis S1959 strain protected
that strain from the bactericidal action of human serum.
The presence of the core oligosaccharide of LPS on the
P. mirabilis R110 strain was not sufficient to the prevent
the bactericidal effect of complement. In the next exper-
iment the role of the OMPs of P. mirabilis S1959, R110,
and R45 in complement-mediated killing was tested.
Electrophoretic patterns of OMPs 
of smooth and rough P. mirabilis cells
The Bradford protein assay showed that the three
tested P. mirabilis strains contained similar amounts of
OMPs, i.e. 1.2, 0.9, and 1.1 mg/ml for the S1959, R110,
and R45 cells, respectively. The OMPs of the P. mirabilis
S1959 strain and its R forms were isolated and analyzed
using SDS-PAGE. The analysis, presented in Fig. 1,
shows that there are differences between P. mirabilis
S1959 and its LPS mutant forms with regard to OMP
expression. The P. mirabilis S1959 strain, which is resis-
tant to the bactericidal action of human serum, pos-
sessed only ten OMPs, with the 36-, 24-, and 18-kDa
proteins predominating. The Ra (R110) and Re (R45)
mutants contained 22 and 21 OMPs, respectively (Fig.
1). The two R mutants differed by the presence of 116-,
40-, 39-, and 19-kDa proteins. These R mutants pro-
duced several proteins in excess which were in lower
quantities than those isolated from the serum-resistant
strain P. mirabilis S 1959. It is worth mentioning that we
observed hyperproduction of 33- and 35-kDa OMPs by
the Ra (R110) and of 33-kDa OMP by the Re (R45)
LPS mutants. These proteins were not present in the P.
mirabilis S1959 strain. The presence and ratios of OMPs
in concert with the composition of the LPSs may play an
essential role in protecting the P. mirabilis rods from the
bactericidal action of human complement. 
Complement binding and C3 fragmentation 
by P. mirabilis S and R LPSs
In the next set of experiments we tried to find
whether complement-mediated P. mirabilis lysis is
accompanied by C binding and C3 fragmentation.
Complement fixation by lyophilized cells of the P. mi-
rabilis S1959 smooth strain and the two rough mutants
and their respective LPSs were tested with sensitized
sheep erythrocytes. The fixation of human complement
proteins, Proteus cells and erythrocytes resulted in
hemoglobin release (Fig. 2A). The P. mirabilis R 45 (Re
type) lyophilized cells were much less potent in comple-
ment fixation than the R 110 (Ra type) and S1959
(smooth type) cells (Fig. 3A). This may be due to the
differences in OMPs and the composition of the poly-
saccharide part of the LPSs. LPSs were isolated from
the smooth P. mirabilis S1959 and the two mutant
strains and the human complement-binding abilities
were tested (Fig. 2B). In contrast to the P. mirabilis
S1959 lyophilized cells, the isolated S1959 LPS was not
effective in human complement fixation. The R110 LPS
had reduced complement fixation abilities compared
with R45 LPS. This suggests that the complete core of
R110 LPS prevented these activities.
Fig. 1. The densitograms of OMPs from P. mirabilis. Molecular masses of the OMPs were analysed with Quantity One v. 4.0.1 software.
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C3 conversion resulted in MAC formation and bac-
terial lysis (Biedzka-Sarek et al. 2005). The conversion
of native C3 to a series of low-molecular-mass frag-
ments such as C3b, iC3b, and C3c was estimated by cap-
ture ELISA and crossed immunoelectophoresis.
Smooth S1959 LPS was used to see whether there is a
dose-dependent increase in C3c neo-epitopes (Fig. 3). A
C3c increase was observed with S1959 LPS at concen-
trations of 0.083 to 83 µg/ml. In the next experiment, the
dose of LPS in the middle of the range, i.e. 10 µg/ml, was
used to compare C3c generation (Fig. 4). The S1959,
R110, and R45 LPSs induced increases in the relative
amounts of C3c neo-epitopes above the control serum
level in a statistically significant way (p<0.05). The
potencies of the P. mirabilis S1959 and R110 LPSs to
induce an increase in the amount of C3c neo-epitopes
did not differ, in contrast to R45 LPS, which had a lower
ability (Fig. 4). This is in agreement with the total com-
plement fixation test. R45 LPS was less effective in C
binding than R110 LPS (Fig. 2B). 
The crossed immunoelectophoresis method con-
firmed the capture ELISA data demonstrating that the
native C3 is converted to C3c and other low-molecular-
-mass fragments after exposure to the LPSs. The incu-
bation of normal serum with the LPSs O10, S1959,
R110, R45, R595, and fragments of LPSs resulted in the
conversion of C3 to fast-migrating lower-molecular-
mass fragments, probably representing C3b, iC3b, and
C3c. (Fig. 5A). The rabbit anti-human C3c antibodies
were not specific to the C3 break-down fragments, but
precipitated the native C3 as well. However, the C3 con-
version by the LPSs was accompanied by a decrease in
precipitates with native C3 and increased the amount of
faster-migrating C3c and other low-molecular-mass C3
fragments. C3 fragmentation was minimal with control
serum alone (Fig. 5A panel 8). Regardless of the type of
the polysaccharide structure, the S and R forms of 
P. mirabilis LPSs fragmented C3 to C3c and were then
detected by anti-C3c antibodies (Fig. 5A). P. mirabilis
S1959, O10 (both S type), R110 (Ra), R45 (Re), and 
S. minnesota 595 (Re) LPSs fragmented the C3 into
smaller, faster-migrating components. The lipid A part
of LPS O10 and the O-specific polysaccharide (F1S1959)
also converted C3 to low-molecular-mass components. 
To find the pathway involved in the C3 fragmenta-
tion induced by the LPSs, human C1q-deficient serum
(C1qD, with only the antibody-independent classical
pathway active) was used. In C1qD serum only two Re
type LPSs, i.e. P. mirabilis R45 and S. minnesota 595,
fragmented C3 (Fig. 2B panels 3 and 6). This result
clearly shows that the antibody-independent classical
pathway of activation is involved in C3 fragmentation by
the Re type of LPSs. The presence of the core oligosac-
charide (R110 LPS) and O-specific polysaccharides
(S1959, O10 LPSs) inhibit that way of C3 conversion.
Depleted of 2-keto-3-deoxyoctulosonic (KDO)
residues, the lipid A part of P. mirabilis O10 LPS does
not fragment the C3 complement component by the
antibody-independent classical pathway of activation.
This may suggest a role of KDO of the Re type of LPS
in the above way of C3 conversion.
Fig. 2. Complement fixation by smooth and rough P. mirabilis dry
masses (A) and lipopolysaccharides (B). The residual complement
activity with antibody-sensitized sheep erythrocytes was deter-
mined as described in Materials and Methods.
Fig. 3. C3 conversion under the influence of different doses of 
P. mirabilis S1959 LPS. Serial dilutions of P. mirabilis S1959 LPS
in PBS were incubated for 45 min at 37°C in a water bath with 40
µl of serum (80% final concentration). Then a mixture of LPS and
serum was diluted 1:2000 in ice-cold PBS supplemented with 10
mM EDTA, 0.02% Tween (pH 7.3). From this, 50 µl of solution
were transferred to microtiter plates pre-coated with rabbit anti-
human C3c antibodies and the amounts of C3c neo-epitopes were
determined by HRP-conjugated rabbit anti-human C3c antibodies
as described in Materials and Methods. 
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DISCUSSION
In the present study we showed C3 fragmentation to
low-molecular-mass components containing C3c neo-
-epitopes. C3 conversion was observed with P. mirabilis
S, Ra, and Re type LPSs, which differ in the polysac-
charide parts linked to lipid A. C3 fragmentation with
antibody-depleted serum (C1qD) showed that the O-
-polysaccharide and core oligosaccharide attached to
lipid A Proteus LPSs prevented the complement compo-
nents of C3 conversion by the antibody-independent
classical pathway. Only the heptose-less Re type LPSs
(P. mirabilis R45 and S. minnesota 595) fragmented C3
in the serum with the antibody-independent classical
pathway (C1qD) active. These results are in agreement
with data on the inhibition of complement-mediated
hemolysis showing that heptose residues of the core
oligosaccharide prevent the classical pathway of com-
plement activation and the alternative pathway might
start instead (Biedzka-Sarek et al. 2005; Gardiner et al.
1991; Vukajlovich et al. 1987). The heptose residues are
present in the core oligosaccharide of the Proteus Ra
types and the smooth form of LPSs.
Whether the electric is negative or positive appears
to dictate which pathway of the complement system is
activated. Negatively charged liposomes activate com-
plement via the classical pathway, whereas those posi-
tively charged are responsible for complement activa-
tion via the alternative pathway (Chonn et al. 1991;
Klink et al. 1998; Munstermann et al. 1999). The tested
Proteus LPSs are positively and negatively charged
(Ró¿alski et al. 1997). Therefore, Proteus LPSs might
activate complement by both pathways. 
The lower amount of C3c neo-epitope generation by
R45 than by R110 LPS correlates with the total comple-
ment binding by those LPSs in the hemolytic comple-
ment assay. Correlation in complement binding
between lyophilized P. mirabilis S1959 bacterial cells
and the respective LPS was not observed. The former
effectively binds human complement, in contrast to the
isolated S1959 LPS. This may indicate that OMPs
exposed on the bacterial cell wall may prevent comple-
ment deposition on the core-lipid A part of S1959 LPS.
This effect was not possible with isolated S1959 LPS. 
Complement system activation is an important factor
in the human defense system against bacterial pathogens
(Burns and Hull 1998; Fischer et al. 1997; Joiner et al.
1986; Nawrot et al. 1995; Ram et al. 1998). The presence
of O-polysaccharide on the surface of the P. mirabilis
S1959 strain protected that strain from complement-
mediated lysis. The presence of a core oligosaccharide on
P. mirabilis R110 (Ra type) was not sufficient to make
that strain serum resistant. The serum resistance of
smooth P. mirabilis S1959 (belonging to the O3
serogroup) is in line with those of the other smooth P.
mirabilis O10, O23, O30, and O43 strains (Kaca et al.
2000). The importance of long-chain O-polysaccharide
Fig. 4. Capture ELISA determination of C3 conversion to C3c
neo-epitopes in normal serum under the influence of the smooth
and rough forms of P. mirabilis S1959, R110, and R45 LPS. 10 µl
of LPS (1 mg/ml) were incubated for 45 min at 37°C in a water
bath with 40 µl of serum (80% final concentration). Then C3c neo-
epitopes were determined as described under Fig. 3 and in
Materials and Methods. All values in this study are expressed as
the mean ±SEM from six measurements. The differences between
variations (compared with S1959) were analyzed by ANOVA.
Fig. 5. Crossed immunoelectrophoresis with normal (A) and com-
plement-deficient (B) human serum. Complement was activated
for 45 min at 37°C by S and R forms of P. mirabilis and S. min-
nesota 595 LPS. C3 conversion was detected with rabbit anti-
-human C3c antibodies as described in Materials and Methods.
Complement-deficient serum (B), i.e. antibody-, C1q-, D-, P-, and
MBL-deficient human serum, was supplemented with 10% C1q
and that restored the classical antibody-independent pathway of
complement activation (serum designated as C1qD). Panels: 1 –
S1959 LPS, 2 – R110 LPS, 3 – R45 LPS, 4 – F1S1959, 5 – lipid A
O10, 6 – 595 LPS, 7 – O10 LPS, 8 – control serum alone. The
anode is to the right.
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LPS protecting bacteria from human serum has also been
observed by others (Joiner et al. 1986; Nawrot et al. 1995;
Ram et al. 1998). One can postulate that the smooth LPS
forms activate complement and deposit C3 on the long
polysaccharide chains and in this way keep MAC forma-
tion at a distance from the bacterial cell membrane. 
Well-known reports (Doroszkiewicz and Lachowicz
1989; Reeves 1995) and our own research (Cisowska et
al. 2005; Futoma-Ko³och et al. 2006; Mielnik et al. 2001)
have shown that many smooth strains demonstrate sen-
sitivity to the bactericidal action of complement. The
participation of OMPs has been suggested in bacterial
serum-resistance phenomena by their inhibition of com-
plement activation at the C3, C9, and C5b-9 levels
(Biedzka-Sarek et al. 2005; Pilz et al. 1992; Prasadarao
et al. 2002). The mechanism by which these proteins
decrease the serum susceptibility of the strains is still
not known. It is believed that minimal changes in sur-
face loops of the outer membrane can have a profound
impact on protective immune responses. It has been
shown that OMPs from Klebsiella pneumoniae and
Aeromonas salmonicida activate the classical pathway of
the complement system by forming complexes with C1q,
a component of the complement system (Alberti et al.
1993; Merino et al. 1998). 
The P. mirabilis R110 strain with a Ra-type LPS, i.e.
with a complete core oligosaccharide but devoid of the
O-antigen, and the P. mirabilis R45 strain (Re-type), a
deeply rough strain with a truncated core oligosaccha-
ride, produced about eleven OMPs more than the
smooth P. mirabilis S1959 strain. In conclusion, the long
O-specific polysaccharide part of LPS, probably in con-
cert with OMPs, is responsible for the survival of the
smooth P. mirabilis S1959 strain in human serum. 
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